Details of the Target
General Information of Target
Target ID | LDTP08661 | |||||
---|---|---|---|---|---|---|
Target Name | E3 ubiquitin-protein ligase TRIM22 (TRIM22) | |||||
Gene Name | TRIM22 | |||||
Gene ID | 10346 | |||||
Synonyms |
RNF94; STAF50; E3 ubiquitin-protein ligase TRIM22; EC 2.3.2.27; 50 kDa-stimulated trans-acting factor; RING finger protein 94; RING-type E3 ubiquitin transferase TRIM22; Staf-50; Tripartite motif-containing protein 22
|
|||||
3D Structure | ||||||
Sequence |
MDFSVKVDIEKEVTCPICLELLTEPLSLDCGHSFCQACITAKIKESVIISRGESSCPVCQ
TRFQPGNLRPNRHLANIVERVKEVKMSPQEGQKRDVCEHHGKKLQIFCKEDGKVICWVCE LSQEHQGHQTFRINEVVKECQEKLQVALQRLIKEDQEAEKLEDDIRQERTAWKNYIQIER QKILKGFNEMRVILDNEEQRELQKLEEGEVNVLDNLAAATDQLVQQRQDASTLISDLQRR LRGSSVEMLQDVIDVMKRSESWTLKKPKSVSKKLKSVFRVPDLSGMLQVLKELTDVQYYW VDVMLNPGSATSNVAISVDQRQVKTVRTCTFKNSNPCDFSAFGVFGCQYFSSGKYYWEVD VSGKIAWILGVHSKISSLNKRKSSGFAFDPSVNYSKVYSRYRPQYGYWVIGLQNTCEYNA FEDSSSSDPKVLTLFMAVPPCRIGVFLDYEAGIVSFFNVTNHGALIYKFSGCRFSRPAYP YFNPWNCLVPMTVCPPSS |
|||||
Target Bioclass |
Enzyme
|
|||||
Family |
TRIM/RBCC family
|
|||||
Subcellular location |
Cytoplasm
|
|||||
Function |
Interferon-induced E3 ubiquitin ligase that plays important roles in innate and adaptive immunity. Restricts the replication of many viruses including HIV-1, encephalomyocarditis virus (EMCV), hepatitis B virus (HBV), hepatitis C virus (HCV) or Zika virus (ZIKV). Mechanistically, negatively regulates HCV replication by promoting ubiquitination and subsequent degradation of viral NS5A. Acts also by promoting the degradation of Zika virus NS1 and NS3 proteins through proteasomal degradation. Acts as a suppressor of basal HIV-1 LTR-driven transcription by preventing Sp1 binding to the HIV-1 promoter. Plays also a role in antiviral immunity by co-regulating together with NT5C2 the RIGI/NF-kappa-B pathway by promoting 'Lys-63'-linked ubiquitination of RIGI, while NT5C2 is responsible for 'Lys-48'-linked ubiquitination of RIGI. Participates in adaptive immunity by suppressing the amount of MHC class II protein in a negative feedback manner in order to limit the extent of MHC class II induction.
|
|||||
Uniprot ID | ||||||
Ensemble ID | ||||||
HGNC ID |
Target Site Mutations in Different Cell Lines
Probe(s) Labeling This Target
ABPP Probe
Probe name | Structure | Binding Site(Ratio) | Interaction ID | Ref | |
---|---|---|---|---|---|
DBIA Probe Info |
![]() |
C441(2.09) | LDD3339 | [1] | |
IA-alkyne Probe Info |
![]() |
C416(0.00); C97(0.00) | LDD0167 | [2] |
Competitor(s) Related to This Target
Competitor ID | Name | Cell line | Binding Site(Ratio) | Interaction ID | Ref |
---|---|---|---|---|---|
LDCM0625 | F8 | Ramos | C140(1.39); C441(0.63) | LDD2187 | [3] |
LDCM0572 | Fragment10 | Ramos | C140(0.70) | LDD2189 | [3] |
LDCM0573 | Fragment11 | Ramos | C140(4.97); C441(0.42) | LDD2190 | [3] |
LDCM0574 | Fragment12 | Ramos | C140(0.58) | LDD2191 | [3] |
LDCM0576 | Fragment14 | Ramos | C140(2.06); C441(0.78) | LDD2193 | [3] |
LDCM0579 | Fragment20 | Ramos | C140(0.51) | LDD2194 | [3] |
LDCM0582 | Fragment23 | Ramos | C140(1.06) | LDD2196 | [3] |
LDCM0586 | Fragment28 | Ramos | C140(0.24) | LDD2198 | [3] |
LDCM0588 | Fragment30 | Ramos | C140(1.89) | LDD2199 | [3] |
LDCM0589 | Fragment31 | Ramos | C140(1.50) | LDD2200 | [3] |
LDCM0590 | Fragment32 | Ramos | C140(0.92) | LDD2201 | [3] |
LDCM0468 | Fragment33 | Ramos | C140(1.43) | LDD2202 | [3] |
LDCM0596 | Fragment38 | Ramos | C140(1.22) | LDD2203 | [3] |
LDCM0566 | Fragment4 | Ramos | C140(0.83); C441(0.47) | LDD2184 | [3] |
LDCM0614 | Fragment56 | Ramos | C140(1.02) | LDD2205 | [3] |
LDCM0569 | Fragment7 | Ramos | C140(0.73); C441(0.41) | LDD2186 | [3] |
LDCM0571 | Fragment9 | Ramos | C140(0.55) | LDD2188 | [3] |
LDCM0022 | KB02 | T cell-activated | C337, C347(5.09) | LDD1708 | [4] |
LDCM0023 | KB03 | Ramos | C140(1.09); C441(0.40) | LDD2183 | [3] |
LDCM0024 | KB05 | NALM-6 | C441(2.09) | LDD3339 | [1] |
The Interaction Atlas With This Target
References